CLINICAL_TRIALS
trial_result
· 2019-11-25
Clinical Trial Update: Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia [Phase 3]
Summary
Phase 3 trial of Lu AF35700 in treatment-resistant schizophrenia completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: H. Lundbeck A/S | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2019-11-25